ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.60
0.71%
US Tech 100
19,636.04
0.55%
S&P 500
5,770.20
0.55%
US Dollar vs CAD
1.43715
0.00%
Bitcoin
82,798.42
-3.90%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) News

AMGN

Amgen (AMGN)

Amgen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AMGN
DateTimeSourceHeadlineSymbolCompany
03/08/20255:00AMPR Newswire (US)AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITISNASDAQ:AMGNAmgen Inc
03/08/20255:00AMPR Newswire (US)AMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITISNASDAQ:AMGNAmgen Inc
03/05/20257:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20257:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20257:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20257:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20257:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20257:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20256:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20256:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20256:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/05/20256:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
03/04/20253:54PMPR Newswire (US)AMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDENDNASDAQ:AMGNAmgen Inc
03/01/20254:30PMPR Newswire (US)POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPSNASDAQ:AMGNAmgen Inc
02/28/20253:01PMPR Newswire (US)AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCENASDAQ:AMGNAmgen Inc
02/27/20259:10AMPR Newswire (US)Oncology Breakthroughs: How Cancer Research Is Advancing in 2025NASDAQ:AMGNAmgen Inc
02/27/20259:04AMPR Newswire (Canada)Oncology Breakthroughs: How Cancer Research Is Advancing in 2025NASDAQ:AMGNAmgen Inc
02/27/20259:04AMPR Newswire (US)Oncology Breakthroughs: How Cancer Research Is Advancing in 2025NASDAQ:AMGNAmgen Inc
02/21/20257:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
02/21/20257:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
02/21/20253:27PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMGNAmgen Inc
02/20/20257:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
02/19/20253:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMGNAmgen Inc
02/19/20253:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMGNAmgen Inc
02/19/20251:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMGNAmgen Inc
02/18/20253:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMGNAmgen Inc
02/14/20253:18PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMGNAmgen Inc
02/14/20253:01PMPR Newswire (US)AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMITNASDAQ:AMGNAmgen Inc
02/13/20258:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMGNAmgen Inc
02/11/20252:01PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMGNAmgen Inc
 Showing the most relevant articles for your search:NASDAQ:AMGN

Your Recent History

COIN
BTCUSD
Bitcoin
USOTC
AABB
Asia Broadband (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
NASDAQ
AMRN
Amarin
NASDAQ
TSLA
Tesla
NASDAQ
COOP
Mr Cooper
USOTC
GVSI
Good Vibrations Shoes (PK)
COIN
XRPUSD
Ripple
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
RDAR
Raadr (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
RDGL
Vivos (QB)
USOTC
HMBL
HUMBL (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads